Indeed, the RANKL/RANK pathway is involved not only in osteoclasts, but also in many other cells of the tumor environment, including osteoblasts, stromal cells, immune cells (T and B lymphocytes, dendritic cells), and endothelial cells. This evidence concerns the gene TNFRSF11A and neoplasm.